Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04849949
Other study ID # AWD00006706
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 10, 2017
Est. completion date February 27, 2018

Study information

Verified date April 2021
Source University of Georgia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Walnuts are a nutrient dense food, but most health research is on English walnuts (EW). Black walnuts (BW) contain a different antioxidant and fatty acid profile, and more protein, compared to EW. The purpose of the study was to compare postprandial responses following the consumption of 3 breakfast meals containing either butter (control), BW, or EW.


Description:

This study was a randomized, double-blind control trial consisting of 3 study visits for 3 different treatments. The treatments were high-fat breakfast muffins containing either butter (control), black walnuts, or English walnuts. The investigators recruited healthy, normal-weight adults between the ages of 15 and 45y. Study visits were completed in a random order with at least 72 hours between each visit. Anthropometrics, questionnaires, and fasting and postprandial blood samples were collected at each visit. Hypothesis: The walnut-containing meals would mitigate post-meal increases in glucose, insulin, triglycerides (TG), and lipid peroxidation while improving all measures of subjective appetite and TAC compared to the traditional meal without nuts.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date February 27, 2018
Est. primary completion date February 27, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Healthy adult men and women - Normal-weight (body mass index = 18-24.9kg/m2) Exclusion Criteria: - Allergies to test meal ingredients (gluten, eggs, or nuts) - Medication/supplement usage - Chronic disease - Pregnancy or plans to become pregnant - Special diets - Tobacco use

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Control
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Black walnut
Participants in this group received a muffin in which part of the butter was substituted out for black walnuts.
English walnut
Participants in this group received a muffin in which part of the butter was substituted out for English walnuts.

Locations

Country Name City State
United States University of Georgia - Department of Foods and Nutrition & Department of Food Science and Technology Athens Georgia

Sponsors (1)

Lead Sponsor Collaborator
University of Georgia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in triglycerides (TG) and glucose responses TG (mg/dL) and glucose (mg/dL) Change from baseline to 3 hours postprandially
Primary Change in lipid peroxidation Malondialdehyde (MDA) (uM) measured via Thiobarbituric acid reactive substances (TBARS) assay Change from baseline to 3 hours postprandially
Primary Change in total antioxidant capacity Total antioxidant capacity (uM trolox equivalents) measured via Oxygen Radical Absorbance Capacity (ORAC) assay. Change from baseline to 3 hours postprandially
Primary Change in insulin Insulin (uU/mL) Change from baseline to 3 hours postprandially
Secondary Change in angiopoietin-like proteins-3 (ANGPTL3) and -4 (ANGPTL4) responses ANGPTL3 (pg/mL) and ANGPTL4 (pg/mL) Change from baseline to 3 hours postprandially
Secondary Change in hunger and satiety responses Hunger, fullness, prospective consumption, and desire to eat measured via a Visual Analog Scale (VAS) (mm). The range of scores on the continuous VAS is 0-100 mm. Zero represents no hunger, fullness, prospective consumption, and desire to eat, while 100 represents the greatest feeling of these outcomes. Change from baseline to 3 hours postprandially
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1